Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' reply

Aliment Pharmacol Ther. 2022 Jun;55(12):1590-1591. doi: 10.1111/apt.16966.

Authors

Vivek C Goodoory^{1

2}, Cho Ee Ng³, Christopher J Black^{1

2}, Alexander C Ford^{1

2}

Affiliations

¹ Leeds Institute of Medical Research at St. James's University of Leeds, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
³ County Durham and Darlington NHS Foundation Trust, Durham, UK.

PMID: 35610938
DOI: 10.1111/apt.16966

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cost of Illness
Diarrhea
Humans
Irritable Bowel Syndrome* / epidemiology
Prevalence